Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals

AIDS Research and Human Retroviruses

Volumn 20, Issue 9, 2004, Pages 972-988

  Mestecky, Jiri ^a,b   Jackson, Susan ^a   Moldoveanu, Zina ^a   Nesbit, Lorie R ^a   Kulhavy, Rose ^a   Prince, Shirley J ^a   Sabbaj, Steffanie ^a   Mulligan, Mark J ^a   Goepfert, Paul A ^a  

^a University of Alabama at Birmingham Hospital   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LACRIMAL FLUID; MALE; NOSE SECRETION; PRIORITY JOURNAL; SALIVA; SERUM; SPERM; URINE; VAGINA SECRETION; WESTERN BLOTTING;

ADULT; ANTIBODY SPECIFICITY; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; MUCOUS MEMBRANE;

EID: 5644235133     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.972     Document Type: Article

References (129)

1. Wright PF, Kozlowski PA, Rybczyk GK, et al.: Detection of mucosal antibodies in HIV-infected individuals. AIDS Res Hum Retroviruses 2002;18:1291-1300.
2. Archibald DW, Witt DJ, Craven DE, Vogt MW, Hirsch MS, and Essex M: Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J Infect Dis 1987;156:240-241.
3. Archibald D, Hebert CA, Alger LS, and Johnson JP: Detection of HIV-specific antibodies in saliva and cervical secretions. Vaccine Res 1992;1:215-219.
4. Archibald DW, Barr CE, Torosian JP, McLane MF, and Essex M: Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex. J Infect Dis 1987;155:793-796.
5. Archibald DW, Johnson JP, and Prasanna N: Detection of salivary immunoglobulin A antibodies to HIV-1 in infants and children. J Acquir Immune Defic Syndr 1990;4:417-420.
6. Archibald DW, Zon L, Groopman JE, McLane MF, and Essex M: Antibodies to human-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. Blood 1986;67:831-834.
7. Artenstein AW, VanCott TC, Sitz KV, et al.: Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information. J Infect Dis 1997;175:265-271.
8. Becquart P, Hocini H, Lévy M, Sépou A, Kazatchkine MD, and Bélec L: Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrums and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J Infect Dis 2000;181:532-539.
9. Becquart P, Hocini H, Garin B, Sépou A, Kazatchkine MD, and Bélec L: Compartmentalization of the IgG immune response to HIV-1 in breast milk. AIDS 1999;13:1323-1331.
10. Bélec L, Dupre T, Prazuck T, et al.: Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:691-697.
11. Bélec L, Georges AJ, Steenman G, and Martin PM: Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis 1989;160:385-391.
12. Bélec L, Georges AJ, Steenman G, and Martin PM: Antibodies to human immunodeficiency virus in the semen of heterosexual men. J Infect Dis 1989;159:324-327.
13. Bélec L, Meillet D, Gaillard O, et al.: Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS. Clin Exp Immunol 1995;101:100-106.
14. Bélec L, Tevi-Benissan C, Dupre T, et al.: Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection. J Clin Immunol 1996;16:12-20.
15. Bélec L, Tévi-Bénissan C, Grésenguet G, Meillet D, and Pillot J: HIV-1 antibody serum negativity with vaginal secretions positivity. Lancet 1994;343:1046-1047.
16. Bélec L, Tevi-Benissan C, Lu XS, Prazuck T, and Pillot J: Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res Hum Retroviruses 1995;11:719-729.
17. Broliden K, Hinkula J, and Devito C: Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol Lett 2001;79:29-36.
18. Buchacz K, Parekh BS, Padian NS, et al.: HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men. AIDS Res Hum Retroviruses 2001;17:1689-1693.
19. Cao Y, Friedman-Kien AE, Chuba JV, and Mirabile M: IgG antibodies to HIV-1 in urine of HIV-1 seropositive individuals. Lancet 1988;1:831-832.
20. Cartry O, Moja P, Quesnel A, Pozzetto B, Lucht FR, and Genin C: Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol 1997;109:47-53.
21. Beyrer C, Artenstein AW, Rugpao S, et al.: Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 1999;179:59-67.
22. Chuachoowong R, Shaffer N, Van Cott TC, et al.: Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand. J Infect Dis 2000;181:1957-1963.
23. Clerici M, Barassi C, Devito C, et al.: Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41. AIDS 2002;16:1731-1741.
24. Connell JA, Parry JV, Mortimer PP, and Duncan J: Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine. J Med Virol 1993;41:159-164.
25. Devito C, Hinkula J, Kaul R, et al.: Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr 2002;30:413-420.
26. Duprat C, Mohammed Z, Datta P, et al.: Human immunodeficiency virus type 1 IgA antibody in breast milk and serum. Pediatr Infect Dis J 1994;13:603-608.
27. Fiore JR, Laddago V, Kepera A, et al.: Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: Lack of correlation to genital viral shedding. Microbiologica 2000;23:85-92.
28. LoCaputo S, Trabattoni D, Vichi F, et al.: Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 2003;17:531-539.
29. Devito C, Broliden K, Kaul R, et al.: Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 2000;165:5170-5176.
30. Devito C, Hinkula J, Kaul R, et al.: Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 2000;14:1917-1920.
31. Dorrell L, Hessell AJ, Wang M, et al.: Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS 2000;14:1117-1122.
32. Vall Mayans MV, Casabona J, Rabella N, De Miniac D, and the Ad Hoc Group for the Comparative Saliva and Serum Study: Testing of saliva and serum for HIV in high-risk populations. Eur J Clin Microbiol Infect Dis 1995;14:710-713.
33. Williams SB, Flanigan TP, Cu-Uvin S, et al.: Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin Infect Dis 2002;35:611-617.
34. Battle-Miller K, Eby CA, Landay AL, Cohen MH, Sha BE, and Baum LL: Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1-infected women. J Infect Dis 2002;185:439-447.
35. Freerichs RR, Htoon MT, Eskes N, and Lwin S: Comparison of saliva and serum for HIV surveillance in developing countries. Lancet 1992;340:1496-1500.
36. Funkhouser A, Clements ML, Slome S, Clayman B, and Viscidi R: Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients. AIDS Res Hum Retroviruses 1993;9:627-632.
37. Haimovici F, Mayer KH, and Anderson DJ: Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:185-191.
38. Hocini H, Bélec L, Iscaki S, et al.: High-level ability of secretory IgA to block HIV type 1 transcytosis: Contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses 1997;13:1179-1185.
39. Holmstrom P, Syrjanen L, Laine S, Valle PSL, and Suni J: HIV antibodies in whole saliva detected by ELISA and Western-blot assays. J Med Virol 1990;30:245-248.
40. Jackson S, Prince S, Kulhavy R, and Mestecky J: False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens. AIDS Res Hum Retroviruses 2000;16:595-602.
41. Janoff EN, Scamurra RW, Sanneman TC, Eidman K, and Thurn JR: Human immunodeficiency virus type 1 and mucosal humoral defense. J Infect Dis 1999;179(Suppl. 3):S475-479.
42. Johnson AM, Parry JV, Best SJ, Smith AM, DeSilva M, and Mortimer PP: HIV surveillance by testing saliva. AIDS 1988;2:369-371.
43. Kaul R, Trabattoni D, Bwayo JJ, et al.: HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23-29.
44. Kozlowski PA, and Jackson S: Serum IgA subclasses and molecular forms in HIV infection: Selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins. AIDS Res Hum Retroviruses 1992;8:1773-1778.
45. Kozlowski PA, Black KP, Shen L, and Jackson S: High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. J Immunol 1995;154:6163-6173.
46. Kozlowski PA, Chen D, Eldridge JH, and Jackson S: Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals. AIDS Res Hum Retroviruses 1994;10:813-822.
47. Lü FX: Predominate HIV-1-specific IgG activity in various mucosal compartments of HIV-1-infected individuals. Clin Immunol 2000;97:59-68.
48. Lu NS, Bélec L, Martin PMV, and Pillot J: Enhanced local immunity in vaginal secretions of HIV-infected women. Lancet 1991;338:323-324.
49. Lu XS, Bélec L, and Pillot J: Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J Infect Dis 1993;167:1189-1192.
50. Lu XS, Delfraissy JF, Grangeot-Keros L, Rannou MT, and Pillot J: Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype. Res Virol 1994;145:369-377.
51. Matsuda S, Oka S, Honda M, Takebe Y, and Takemori T: Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages. Scand J Immunol 1993;38:428-434.
52. Mazzoli S, Lopalco L, Salvi A, et al.: Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. J Infect Dis 1999;180:871-875.
53. Mazzoli S, Trabattoni D, Lo Caputo S, et al.: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-1257.
54. Mohamed OA, Ashley R, Goldstein A, McElrath J, Dalessio J, and Corey L: Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method. J Acquir Immune Defic Syndr 1994;7:375-380.
55. Moja P, Tranchat C, Tchou I, et al.: Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J Infect Dis 2000;181:1607-1613.
56. Nielsen K, Boyer P, Dillon M, et al.: Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis 1996;173:1001-1004.
57. O'Shea S, Cordery M, Barrett WY, Richman DD, Bradbeer C, and Banatvala JE: HIV excretion patterns and specific antibody responses in body fluids. J Med Virol 1990;31:291-296.
58. Raux M, Finkielsztejn L, Salmon-Ceron D, et al.: Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients. J Immunol Methods 1999;222:111-124.
59. Raux M, Finkielsztejn L, Salmon-Ceron D, et al.: Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1999;15:1365-1376.
60. Renom G, Bouguety JC, Lanckviet C, Georges AJ, Siopathis MR, and Martin PMV: HIV specific IgA antibodies in tears of children with AIDS or at risk of AIDS. Res Virol 1990;141:355-363.
61. Skurnick JH, Palumbo P, DeVico A, et al.: Correlates of non-transmission in US women at high risk of human immunodeficiency virus Type 1 infection through sexual exposure. J Infect Dis 2002;185:428-438.
62. Stark K, Warnecke C, Brickmann V, Gelderblom HR, Bienzle U, and Pauli G: Sensitivity of HIV antibody detection in saliva. Med Microbiol Immunol 1993;182:147-151.
63. Sun D, Archibald DW, and Furth PA: Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage. AIDS Res Hum Retroviruses 1990;6:933-941.
64. Urnovitz HB, Sturge JC, Gottfried TD, and Murphy WH: Urine antibody tests: New insight into the dynamics of HIV-1 infection. Clin Chem 1999;45:1602-1613.
65. Urnovitz HB, Clerici M, Shearer GM, et al.: HIV-1 antibody serum negativity with urine positivity. Lancet 1993;342:1458-1459.
66. van de Perre P, Hitimana D-G, and Lepage P: Human immunodeficiency virus antibodies of IgG, IgA, and IgM subclasses in milk of seropositive mothers. J Pediatr 1998;113:1039-1041.
67. Wolff H, Mayer K, Seage G, Politch J, Horsburgh CR, and Anderson D: A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men. J Acquir Immune Defic Syndr 1992;5:65-69.
68. Wu X and Jackson S: Plasma and salivary IgG subclasses in HIV type 1 infection: Evidence of both transudation and local synthesis of IgG in parotid saliva. AIDS Res Hum Retrovirus 2000;16:1423-1431.
69. Wu X and Jackson S: Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals. J Clin Immunol 2002;22:106-115.
70. Jackson S, Mestecky J, Moldoveanu Z, and Spearman P: Collection and processing of human mucosal secretions. In: Mucosal Immunology, 2nd Ed. (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds.). Academic Press, San Diego, 1999, pp. 1567-1576.
71. Kozlowski PA, Lynch RM, Patterson RR, Cu-Uvin S, Flanigan TP, and Neutra MR: Modified wick method using weck-cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. J Acquir Immune Defic Syndr 2000;24:297-309.
72. Mestecky J, Jackson S, Moldoveanu Z, et al.: Manual for Collection and Processing of Mucosal Specimens. DAIDS, NIH, Bethesda, MD, 1999.
73. Quesnel A, Cu-Uvin S, Murphy D, Ashley RL, Flanigan T, and Neutra MR: Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J Immunol Methods 1997;202:153-161.
74. Mestecky J and Kilian M: Immunoglobulin A (IgA). Methods Enzymol 1985;116:37-75.
75. Czerkinsky C: Antibody secreting cells. In: Methods of Enzymatic Analysis (Bergmeyer HU, Bergmeyer J, and Grassl M, eds.). VCH, Weinheim, Germany, 1986, pp. 23-44.
76. Czerkinsky C, Moldoveanu Z, Mestecky J, Nilsson LA, and Ouchterlony O: A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods 1988;115:31-37.
77. Czerkinsky C, Prince SJ, Michalek SM, et al.: IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci USA 1987;84:2449-2453.
78. Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, and Mestecky J: Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 1995;13:1006-1012.
79. Russell MW, Kilian M, and Lamm ME: Biological activities of IgA. In: Mucosal Immunology, 2nd Ed. (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds.). Academic Press, San Diego, 1999, pp. 225-240.
80. Vermund SH: Transmission of HIV. In: AIDS, 4th Ed. (DeVita V, Hellman S, and Rosenberg SA, eds.). Lippincott-Raven, Philadelphia, PA, 1997, pp. 147-165.
81. Baba TW, Liska V, Hofmann-Lehmann R, et al.: Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000;6:200-206.
82. Mascola JR, Stieglert G, Vancott TC, et al.: Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000:6;207-210.
83. Kozlowski PA and Neutra MR: The role of mucosal immunity in prevention of HIV transmission. Curr Mol Med 2003;3:217-228.
84. Galla JH, Spotswood MF, Harrison LA, and Mestecky J: Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura. J Clin Immunol 1985;5:298-306.
85. Kutteh WH, Moldoveanu Z, and Mestecky J: Mucosal immunity in the female reproductive tract: Correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998;14:S51-55.
86. Kutteh WH, Prince SJ, Hammond KR, Kutteh CC, and Mestecky J: Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin Exp Immunol 1996;104:538-542.
87. Bard E, Riethmuller D, Biichlé S, et al.: Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions. J Immunoassay Immunochem 2002;23:145-162.
88. Lambert JS, Keefer M, Mulligan M et al.: A phase I safety and immunogenicity trial of UBI microparticlate monovalent HIV-1 mn oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Vaccine 2001;19:3033-3042.
89. Wright P, Mestecky J, McElrath J, et al.: Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J Infect Dis 2004;189:122-131.
90. Ferguson A, Humphreys KA, and Croft NM: Technical report: Results of immunological tests on faecal extracts are likely to be extremely misleading. Clin Exp Immunol 1995;99:70-75.
91. Wira CR, Kaushic C, and Richardson: Role of sex hormones and cytokines in regulating the mucosal immune system in the female reproductive tract. In: Mucosal Immunology, 2nd Ed. (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds.). Academic Press, San Diego, 1999, pp. 1449-1461.
92. Mestecky J, Lue C, and Russell MW: Selective transport of IgA. Cellular and molecular aspects. Gastroenterol Clin North Am 1991;20:441-471.
93. Delacroix DL, Hodgson HJF, McPherson A, et al.: Selective transport of polymeric immunoglobulin A in bile: Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest 1982;70:230-241.
94. Kubagawa H, Bertoli LF, Barton JC, Koopman WJ, Mestecky J, and Cooper MD. Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies. J Immunol 1987;138:435-439.
95. McGhee JR, Czerkinsky C, and Mestecky J: Mucosal vaccines- an overview. In: Mucosal Immunology, 2nd Ed. (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds.). Academic Press, San Diego 1999, pp. 741-758.
96. Morris L, Binley JM, Clas BA, et al.: HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998;188:233-245.
97. Pinching AJ: Antibody responses in HIV infection. Clin Exp Immunol 1991;84:181-184.
98. Eriksson K, Kilander A, Hagberg L, Norkrans G, Holmgren J, and Czerkinsky C: Intestinal antibody responses to oral vaccination in HIV-infected individuals. AIDS 1993;7:1087-1091.
99. Kutteh WH and Mestecky J: Concept of mucosal immunology. In: Reproductive Immunology (Bronson RA, Alexander NJ, Anderson D, Branch DW, and Kutteh WH, eds.). Blackwell Science, Cambridge, 1996, pp. 28-51.
100. Hedges SR, Mayo MS, Mestecky J, Hook EW III, and Russell MW: Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect Immun 1999;67:3937-3946.
101. Russell MW and Mestecky J: Humoral immune responses to microbial infections in the genital tract. Microbes Infect 2002;4:667-677.
102. Smith PD and Wahl SM. Immunobiology of mucosal HIV-1 infection. In: Mucosal Immunology, 2nd Ed. (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds.). Academic Press, San Diego, 1999, pp. 977-989.
103. Kozlowski PA and Neutra MR: The role of mucosal immunity in prevention of HIV transmission. Curr Mol Med 2003;3:217-228.
104. Lim SG, Condez A, Lee CA, Johnson MA, Elia C, and Poulter LW: Loss of mucosal CD4 lymphocytes in an early feature of HIV infection. Clin Exp Immunol 1993;92:448-454.
105. + T-cell depletion in HIV disease. Nature 2001;410:974-979.
106. Schneider T, Jahn H-U, Schmidt W, et al.: Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Gut 1995;37:524-529.
107. + T cell depletion and viral replication in SIV infection. Science 1998;280:427-431.
108. Amadori A, Zamarchi R, Ciminale V, et al.: HIV-1 specific B cell activation. J Immunol 1989;143:2146-2152.
109. Chong Y, Ikematsu H, Ariyama I, et al.: Evidence of B cell clonal expansion in HIV type 1-infected patients. AIDS Res Hum Retroviruses 2001;17:1507-1515.
110. Eriksson K, Kilander A, Hagberg L, Norkrans G, Holmgren J, and Czerkinsky C: Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-1 infected individuals. AIDS 1995;9:695-700.
111. Juhuda-Cohen T, Slade BA, and Powell JD: Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Proc Natl Acad Sci USA 1990;87:3972-3976.
112. Mizuma H, Litwin S, and Zolla-Pazner S: B-cell activation of HIV infection: Relationship of spontaneous immunoglobulin secretion to various immunological parameters. Clin Exp Immunol 1998;71:410-416.
113. Moir S, Malaspina A, Ogwaro KM, et al.: HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci USA 2001;98:10362-10367.
114. Nair MPN, Pottathil R, Heimer EP, and Schwartz SA: Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci USA 1988;85:6498-6502.
115. Schnittman SM, Lane HC, Higgins SE, Folks T, and Fauci AS: Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986;233:1084-1086.
116. Shirai A, Cosentino M, Leitman-Klinman SF, and Klinman DM: Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 1992;89:561-566.
117. Zubler RH, Perrin LH, Doucet A, Zhang X, Huang Y-P, and Miescher PA: Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Clin Exp Immunol 1992;87:31-36.
118. Kantele A, Hakkinen M, Moldoveanu Z, et al.: Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun 1998;66:5630-5635.
119. Tarkowski A, Lue C, Moldoveanu Z, Kiyono H, McGhee JR, and Mestecky J: Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J Immunol 1990;144:3770-3778.
120. Lue C, Prince SJ, Fattom A, Schneerson R, Robbins JB, and Mestecky J: Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoid. Infect Immun 1990;58:2547-2554.
121. McGhee JR, Mestecky J, Elson CO, and Kiyono H: Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 1989;9:175-199.
122. McIntyre TM and Strober W: Gut-associated lymphoid tissue regulation of IgA B-cell development. In: Mucosal Immunology, 2nd Ed. (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds.). Academic Press, San Diego, 1999, pp. 319-356.
123. Hörnquist CE, Ekman L, Grdic KD, Schön K, and Lycke NY: Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. J Immunol 1995;155:2877-2997.
124. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, and Zinkernagel RM: A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000;288:2222-2226.
125. Macpherson AJ, Lamarre A, McCoy K, et al.: IgA production without μ or δ chain expression in developing B cells. Nat Immunol 2001;2:625-631.
126. Mayer L, and Blumberg RS: Antigen-presenting cells. Epithelial cells. In: Mucosal Immunology, 2nd Ed. (Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR, eds.). Academic Press, San Diego, 1999, pp. 365-379.
127. Israel ZR and Marx PA: Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees. J Med Primatol 1995;24:53-60.
128. Jackson S, Moldoveanu Z, Mestecky J, et al.: Decreased IgA-producing cells in the gut of SIV-infected rhesus monkeys. Adv Exp Med Biol 1995;371B:1035-1038.
129. Schafer F, Kewenig S, Stolte N, et al.: Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut 2002;50:608-614.